Biochemistry Study Notes: Oxygen-Binding Proteins and Hemoglobin Regulation

Principles of Reversible Protein Binding

• Ligands and Specificity

  • Ligands are defined as any molecules (ranging from small compounds to large macromolecules and other proteins) that bind reversibly to proteins through non-covalent interactions.
  • Ligands bind to discrete, highly specific region on a protein termed the binding site.
  • Binding of a ligand often induces localized or large-scale structural changes in the protein.
  • Enzymes represent a special category of ligand-binding proteins where bound ligands (referred to as substrates) undergo enzymatic chemical transformations at a specialized site called the catalytic site or active site.

• Lock and Key Model

  • Proposed by Emil Fischer in 1894 (who also developed Fischer projections and accomplished the syntheses of caffeine and glucose).
  • Assumes that the binding site of a protein and the ligand possess preformed, perfectly complementary surfaces prior to interaction.
  • Complementarity is dictated by four primary physical attributes: size, shape, charge distribution, and hydrophobic or hydrophilic character.
  • Limitation: Rigidly assumes protein structure remains static upon ligand binding, which was later proven inaccurate for most biological systems.

• Induced Fit Model

  • Proposed by Daniel Koshland in 1958.
  • Represents the accepted model of protein-ligand interactions.
  • Posits that flexible conformational changes occur in both the protein and the ligand upon binding.
  • This structural adaptation (the induced fit) optimizes non-covalent interactions, enabling tighter binding and high affinity across diverse ligands.

Quantitative Thermodynamics and Kinetics of Ligand Binding

• Association and Dissociation Dynamics
  • Consider the reversible association of a protein ($P$) and a ligand ($L$) to form a protein-ligand complex ($PL$):

\n P + L \rightleftharpoons PL\n

*   The forward reaction is governed by the association rate constant ($k_a$), and the reverse reaction is governed by the dissociation rate constant ($k_d$).
*   At dynamic equilibrium, the rate of association equals the rate of dissociation:

\n k_a [P][L] = k_d [PL]\n

*   The **Equilibrium Association Constant** ($K_a$) quantifies affinity and carries units of $M^{-1}$:

\n K_a = \frac{[PL]}{[P][L]} = \frac{k_a}{k_d}\n

*   Higher $K_a$ values correspond to higher affinity of the protein for the ligand.
*   The **Equilibrium Dissociation Constant** ($K_d$) is the reciprocal of $K_a$ and carries units of molarity ($M$):

\n K_d = \frac{1}{K_a} = \frac{[P][L]}{[PL]} = \frac{k_d}{k_a}\n

*   Lower $K_d$ values indicate higher binding affinity.

• Fractional Saturation Derivation
  • The fractional saturation (symbolized by $\theta$) represents the proportion of total protein ligand-binding sites occupied by ligand:

\n \theta = \frac{\text{Bound Sites}}{\text{Total Sites}} = \frac{[PL]}{[PL] + [P]}\n

*   Substituting $[PL] = K_a [L][P]$ into the expression:

\n \theta = \frac{K_a [L][P]}{K_a [L][P] + [P]}\n

*   Canceling free protein concentration ($[P]$) from the numerator and denominator:

\n \theta = \frac{K_a [L]}{K_a [L] + 1} = \frac{[L]}{[L] + \frac{1}{K_a}}\n

*   Expressed in terms of the dissociation constant ($K_d$):

\n \theta = \frac{[L]}{[L] + K_d}\n

*   When the free ligand concentration equals $K_d$ ($[L] = K_d$), exactly half of the binding sites are occupied ($\theta = 0.5$ or $50\%$ saturation).

• Affinity Spectrum Across Biological Interactions
  • The value of $K_d$ varies widely depending on the biological role of the protein-ligand pair:
    • Biotin-avidin: $K_d \approx 10^{-15} \text{ to } 10^{-16}\,M$ (extremely high affinity interaction).
    • Sequence-specific protein-DNA: $K_d \approx 10^{-8} \text{ to } 10^{-12}\,M$.
    • Antibody-antigen: $K_d \approx 10^{-8} \text{ to } 10^{-12}\,M$.
    • Typical receptor-ligand: $K_d \approx 10^{-5} \text{ to } 10^{-9}\,M$.
    • Enzyme-substrate: $K_d \approx 10^{-2} \text{ to } 10^{-6}\,M$ (low relative affinity to facilitate rapid product release and turnover).

Structure and Function of Myoglobin

• Localization and Biological Role

  • Myoglobin is a monomeric, globular protein located in the cytoplasm of muscle cells.
  • Functions as an intracellular oxygen storage protein and facilitates oxygen diffusion in active muscle tissue.
  • Imparts the characteristic red pigment to muscle tissue.

• Tertiary Architecture

  • Consists of a single polypeptide chain of 153 amino acids.
  • Folds into eight distinct $\alpha$-helices designated A through H.
  • Apomyoglobin: The biosynthetic, unfolded or partially folded polypeptide intermediate lacking its bound prosthetic group.
  • Myoglobin: The fully folded, functional holoprotein containing an incorporated Heme B prosthetic group and a single oxygen-binding site.

• Heme B Prosthetic Group Structure and Biosynthesis
  • A prosthetic group is a tightly bound organic or inorganic non-protein cofactor required for protein function.
  • Heme B is a tetrapyrrole porphyrin derivative coordinating a central ferrous iron ion ($Fe(II)$).
  • Biosynthesis: Synthesized in the liver and bone marrow within the mitochondria and cytoplasm via enzymatic condensation of multiple glycine molecules and succinyl-CoA (derived from the citric acid cycle) to produce the porphyrin ring, followed by iron insertion.

*   *Insertion Orientation*: Inserted into a hydrophobic pocket of myoglobin such that:
    *   The **non-polar edge** (containing methyl and vinyl substituents) is buried deep within the hydrophobic interior.
    *   The **polar edge** (containing propionate carboxylate groups, $-COO^-$) points outward toward the hydrophilic aqueous solvent.

• Active Site Coordination Geometry
  • The central ferrous iron atom ($Fe(II)$) forms six coordination bonds:
    • Four coordination bonds are formed with the nitrogens of the four pyrrole rings of the porphyrin system.
    • The fifth coordination bond is formed with the imidazole nitrogen of the Proximal Histidine residue (His F8, the 8th residue of helix F).
    • The sixth coordination position reversibly binds diatomic oxygen ($O_2$).
  • The Distal Histidine residue (His E7, the 7th residue of helix E) does not bond directly to iron, but forms a stabilizing hydrogen bond with the bound $O_2$ molecule.
  • Additional surrounding hydrophobic pocket residues including Valine E11 (Val E11) and Phenylalanine CD1 (Phe CD1) stabilize the bound ligand and protect the iron from irreversible oxidation to ferric iron ($Fe(III)$).

• Myoglobin Binding Kinetics and Calculations
  • Because oxygen is a gas, concentration $[L]$ is substituted by partial pressure ($pO_2$):

\n \theta = \frac{pO_2}{p_{50} + pO_2}\n

*   $p_{50}$ represents the partial pressure of oxygen at which $\theta = 0.5$. For human myoglobin, $p_{50} = 0.37\,\text{kPa}$.
*   Myoglobin exhibits a simple **hyperbolic** binding curve characteristic of a single, non-cooperative binding site.
*   *Sample Calculations*:
    *   At active muscle oxygen tension ($pO_2 = 2\,\text{kPa}$):

\n \theta = \frac{2}{0.37 + 2} = \frac{2}{2.37} \approx 0.84\n

    *   At arterial oxygen tension ($pO_2 = 10\,\text{kPa}$):

\n \theta = \frac{10}{0.37 + 10} = \frac{10}{10.37} \approx 0.96\n

Structure and Conformational Dynamics of Hemoglobin

• Quaternary Architecture

  • Hemoglobin is an oxygen-transporting protein synthesized in red blood cells (erythrocytes).
  • Erythrocytes lack nuclei and mitochondria, functioning essentially as membrane-bound bags filled with hemoglobin.
  • Hemoglobin is a heterotetramer composed of four polypeptide subunits: two $\alpha$ chains and two $\beta$ chains ($\alpha_2\beta_2$).
  • Each individual subunit tertiary structure closely resembles myoglobin, composed predominantly of $\alpha$-helices and containing one Heme B prosthetic group. Thus, a single hemoglobin tetramer can bind up to four $O_2$ molecules.

• Subunit Interfaces

  • The $\alpha_1\beta_1$ and $\alpha_2\beta_2$ dimer interfaces are extremely strong, involving over 30 residue-residue interactions.
  • The $\alpha_1\beta_2$ and $\alpha_2\beta_1$ interfaces are weaker and more dynamic, allowing conformational movement between dimeric units during oxygenation.

• Allosteric Conformations: T and R States

  • Tense State (T state): Corresponding to deoxyhemoglobin. Characterized by lower oxygen affinity, an open central cavity, and stabilization by a complex network of inter-subunit and intra-subunit salt bridges (ion pairs).
  • Relaxed State (R state): Corresponding to oxyhemoglobin. Characterized by high oxygen affinity, rupture of salt bridges, and a narrowed central cavity caused by sliding and rotation of $\alpha\beta$ dimer pairs.

• Structural Basis of T-State Stabilization

  • The T state is stabilized by salt bridges formed by specific residue ion pairs that depend heavily on protonation states.
  • Histidine residues (specifically His HC3, the C-terminal residue of the $\beta$ chain) become protonated into the $+1$ charged state under slightly acidic conditions.
  • Titration properties of free Histidine:
    • Carboxyl group $pK_1 = 1.82$
    • Side chain imidazole group $pK_R = 6.0$
    • Amino group $pK_2 = 9.17$
    • Isoelectric point $pI = 7.59$
  • In the T state, the protonated side chain of $\beta_2$ His HC3 forms an intra-subunit salt bridge with $\beta_2$ Asp FG1, while its C-terminal carboxylate group ($-COO^-$) forms an inter-subunit salt bridge with $\alpha_1$ Lys C5.
  • Similarly, $\beta_1$ His HC3 forms an intra-subunit salt bridge with $\beta_1$ Asp FG1 and an inter-subunit salt bridge with $\alpha_2$ Lys C5.
  • Additionally, $\alpha_1$ Arg HC3 forms inter-subunit salt bridges with $\alpha_2$ Asp H9 and $\alpha_2$ Arg HC3.

• Molecular Mechanism of T-to-R Transition
  • In deoxyhemoglobin (T state), the un-coordinated iron atom sits $0.4\,\text{\AA}$ out of the porphyrin ring plane toward the Proximal His F8.
  • Upon binding $O_2$ at the 6th coordination position, the iron atom is pulled into the plane of the porphyrin ring.
  • This $0.4\,\text{\AA}$ movement pulls the Proximal His F8 and attached F-helix along with it.
  • Structural shift of helix F is transmitted across the $\alpha_1\beta_2$ interface, breaking key salt bridges (including the His HC3 - Asp FG1 interactions) and causing $\alpha\beta$ dimer pairs to slide and rotate relative to each other, shifting the entire tetramer into the high-affinity R state.

Cooperativity and Allosteric Regulation in Hemoglobin

• Sigmoidal Binding Kinetics
  • While myoglobin displays a hyperbolic oxygen binding curve, hemoglobin exhibits a sigmoidal (S-shaped) binding curve.
  • The $p_{50}$ of human hemoglobin is $3.5\,\text{kPa}$ ($26\,\text{mmHg}$), significantly higher than that of myoglobin ($0.37\,\text{kPa}$).
  • A higher $p_{50}$ reflects lower overall apparent oxygen affinity, allowing hemoglobin to unload substantial amounts of oxygen in peripheral tissues.

• Allosteric Definitions

  • An allosteric protein is one in which ligand binding at one specific site affects the binding affinity or activity at a distinct secondary site.
  • Homotropic Effector: The primary ligand itself acts as the allosteric regulator. For hemoglobin, $O_2$ is a homotropic effector, producing positive cooperativity (binding of one $O_2$ increases binding affinity at remaining sites).
  • Heterotropic Effector: A distinct chemical entity alters the binding affinity of the primary ligand. For hemoglobin, protons ($H^+$), carbon dioxide ($CO_2$), and 2,3-bisphosphoglycerate (2,3-BPG) act as negative heterotropic effectors, shifting $p_{50}$ higher and stabilizing the T state.

• Quantitative Description: The Hill Equation

  • Cooperativity across multiple binding sites is modeled quantitatively by the Hill equation using the Hill coefficient ($n_H$):

\n \theta = \frac{pO_2^{n_H}}{p_{50}^{n_H} + pO_2^{n_H}}\n

*   The Hill coefficient ($n_H$) is determined experimentally and reflects the degree of cooperativity (it is not the physical number of binding sites):
    *   $n_H = 1$: Non-cooperative binding (e.g., monomeric myoglobin).
    *   $n_H > 1$: Positive cooperativity (e.g., tetrameric hemoglobin, where $n_H = 3$ across its 4 binding sites).
    *   $n_H < 1$: Negative cooperativity.

• Physiological Efficiency Calculations
  • Comparison at Active Muscle ($pO_2 = 2\,\text{kPa}$, assuming $p_{50} = 3.5\,\text{kPa}$):
    • Non-cooperative ($n_H = 1$):

\n \theta = \frac{2^1}{3.5^1 + 2^1} = \frac{2}{5.5} \approx 0.36\n

    *   Cooperative ($n_H = 3$):

\n \theta = \frac{2^3}{3.5^3 + 2^3} = \frac{8}{42.875 + 8} = \frac{8}{50.875} \approx 0.16\n

*   *Comparison at Lungs* ($pO_2 = 13\,\text{kPa}$, assuming $p_{50} = 3.5\,\text{kPa}$):
    *   Non-cooperative ($n_H = 1$):

\n \theta = \frac{13^1}{3.5^1 + 13^1} = \frac{13}{16.5} \approx 0.79\n

    *   Cooperative ($n_H = 3$):

\n \theta = \frac{13^3}{3.5^3 + 13^3} = \frac{2197}{42.875 + 2197} = \frac{2197}{2239.875} \approx 0.98\n

*   *Conclusion*: Cooperative binding ($n_H = 3$) enables hemoglobin to saturate almost completely in lungs ($\theta = 0.98$) while dropping saturation precipitously in active muscle ($\theta = 0.16$), resulting in a net oxygen delivery efficiency of $82\%$ ($0.98 - 0.16 = 0.82$). A non-cooperative carrier would only deliver $43\%$ ($0.79 - 0.36 = 0.43$).

Environmental and Allosteric Modulation of Oxygen Affinity

• The Bohr Effect
  • Discovered by Christian Bohr in 1904.
  • Actively metabolizing peripheral tissues generate carbon dioxide ($CO_2$) and protons ($H^+$), lowering local pH relative to respiratory organs.

*   Hydration of $CO_2$ catalyzed by carbonic anhydrase produces bicarbonate and protons:

\n CO_2 + H_2O \rightleftharpoons H^+ + HCO_3^-\n

*   Protons ($H^+$) function as negative heterotropic allosteric effectors. Higher $[H^+]$ (lower pH) protonates His HC3, enabling formation of the salt bridge with Asp FG1 and stabilizing the low-affinity T state.
*   Stabilization of the T state promotes oxygen unloading in active tissues.
*   In lungs, high $pO_2$ forces oxygen binding, converting Hb to the R state, which breaks the salt bridges, releasing $H^+$ and driving the conversion of $HCO_3^-$ back into $CO_2$ for exhalation.

• Carbamate Formation by $CO_2$

  • $CO_2$ binds directly and reversibly to the amino-terminal end ($N$-terminus) of each hemoglobin subunit (4 sites per tetramer), forming carbamino-hemoglobin.
  • Carbamate formation releases additional protons ($H^+$), further lowering local pH and enhancing T-state stabilization and oxygen unloading.

• 2,3-Bisphosphoglycerate (2,3-BPG)

  • 2,3-BPG is a highly negatively charged glycolytic metabolite derived from glucose.

*   Present at millimolar ($\text{mM}$) concentrations inside erythrocytes.
*   Functions as a negative heterotropic allosteric effector by binding in the central cavity of hemoglobin.
*   2,3-BPG binds specifically to the T state via electrostatic interactions with positively charged cavity residues. It cannot bind to the R state because the central cavity closes upon oxygenation.

• High-Altitude Physiological Adaptation
  • At Sea Level ($[2,3\text{-BPG}] \approx 5\,\text{mM}$):
    • Lungs ($pO_2 \approx 13.3\,\text{kPa}$): saturation $\approx 98\%$.
    • Tissues ($pO_2 \approx 4\,\text{kPa}$): saturation $\approx 60\%$.
    • Total delivered oxygen $\approx 38\%$.
  • High Altitude ($4,500\,\text{m}$) Before Adaptation ($[2,3\text{-BPG}] \approx 5\,\text{mM}$):
    • Lung $pO_2$ decreases to $\approx 7\,\text{kPa}$, dropping arterial saturation to $\approx 90\%$.
    • Tissue unloading drops to $\approx 30\%$, causing systemic hypoxia.
  • High Altitude Adaptation Mechanics ($[2,3\text{-BPG}]$ increases to $\approx 8\,\text{mM}$):
    • Erythrocytes synthesize additional 2,3-BPG, shifting the binding curve further rightward (increasing $p_{50}$).
    • Although lung loading decreases slightly to $\approx 88\%$, tissue unloading efficiency increases significantly (tissue saturation drops to $\approx 51\%$).
    • Net oxygen delivered to tissues is restored to $\approx 37\%$ ($0.88 - 0.51 = 0.37$).
    • Over longer periods, the body additionally increases red blood cell count and total hemoglobin synthesis.

Pathophysiology: Sickle-Cell Disease (Hemoglobin S)

• Molecular Genetics and Mutation

  • Sickle-cell disease is caused by a point mutation in the gene encoding the $\beta$ subunit of hemoglobin.
  • Resulting variant is designated Hemoglobin S (HbS).
  • The mutation substitutes a charged, hydrophilic Glutamate residue with a non-polar, hydrophobic Valine residue ($Glu \rightarrow Val$) at position 6 of the $\beta$ chain.

• Mechanism of Polymerization

  • The replacement of Glutamate with Valine introduces a prominent hydrophobic patch on the outer surface of $\beta$ subunits.
  • In deoxygenated HbS (T state), this hydrophobic patch interacts directly with a complementary hydrophobic site on a $\beta$ subunit of an adjacent HbS tetramer.
  • This intermolecular interaction drives linear strand assembly, alignment, and crystallization into long, rigid, insoluble protein fibers.

• Pathological and Clinical Consequences
  • Insoluble HbS fibers distort flexible, biconcave erythrocytes into elongated, rigid sickle shapes.
  • Sickled erythrocytes are mechanically fragile, leading to high rates of intravascular hemolysis and underlying severe chronic anemia.
  • Rigid sickled cells lack deformability and lodge in microvascular capillaries, causing painful vaso-occlusive crises, restricting systemic circulation, and producing localized tissue hypoxia and infarction.